Pediatric Neurology Sales Specialist
Launched the first and only oral, non-device diazepam-based medication used for the short-term treatment of seizure clusters in children ages 2 - 5.
With an intuitive sense of market potential, I drive business to the next level. I consistently overcome obstacles and generate product loyalty which results in increasing company profits. I work tirelessly at finding customer solutions for better health outcomes for patients.
Launched the first and only oral, non-device diazepam-based medication used for the short-term treatment of seizure clusters in children ages 2 - 5.